BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17132503)

  • 1. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks.
    Sciandra F; Desiderio C; Vincenzoni F; Viscuso S; Bozzi M; Hübner W; Jimenez-Gutierrez GE; Cisneros B; Brancaccio A
    Biochem Biophys Res Commun; 2024 Apr; 703():149656. PubMed ID: 38364681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoproteomic characterization of recombinant mouse α-dystroglycan.
    Harrison R; Hitchen PG; Panico M; Morris HR; Mekhaiel D; Pleass RJ; Dell A; Hewitt JE; Haslam SM
    Glycobiology; 2012 May; 22(5):662-75. PubMed ID: 22241827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of α-dystroglycan.
    Covaceuszach S; Bozzi M; Bigotti MG; Sciandra F; Konarev PV; Brancaccio A; Cassetta A
    PLoS One; 2017; 12(10):e0186110. PubMed ID: 29036200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAG1 haploinsufficiency is associated with sporadic and familial isolated or pauci-symptomatic hyperCKemia.
    Traverso M; Baratto S; Iacomino M; Di Duca M; Panicucci C; Casalini S; Grandis M; Falace A; Torella A; Picillo E; Onore ME; Politano L; Nigro V; Innes AM; Barresi R; Bruno C; Zara F; Fiorillo C; Scala M
    Eur J Hum Genet; 2024 Mar; 32(3):342-349. PubMed ID: 38177406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural flexibility of human α-dystroglycan.
    Covaceuszach S; Bozzi M; Bigotti MG; Sciandra F; Konarev PV; Brancaccio A; Cassetta A
    FEBS Open Bio; 2017 Aug; 7(8):1064-1077. PubMed ID: 28781947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From adhesion complex to signaling hub: the dual role of dystroglycan.
    Sciandra F; Bozzi M; Bigotti MG
    Front Mol Biosci; 2023; 10():1325284. PubMed ID: 38155958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-Mannosylation and human disease.
    Dobson CM; Hempel SJ; Stalnaker SH; Stuart R; Wells L
    Cell Mol Life Sci; 2013 Aug; 70(16):2849-57. PubMed ID: 23115008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel fluorescent assay for T-synthase activity.
    Ju T; Xia B; Aryal RP; Wang W; Wang Y; Ding X; Mi R; He M; Cummings RD
    Glycobiology; 2011 Mar; 21(3):352-62. PubMed ID: 20959392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.
    Sato Y; Isaji T; Tajiri M; Yoshida-Yamamoto S; Yoshinaka T; Somehara T; Fukuda T; Wada Y; Gu J
    J Biol Chem; 2009 May; 284(18):11873-81. PubMed ID: 19276077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
    Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
    Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defect in glycosylation that causes muscular dystrophy.
    Endo T; Manya H
    Methods Enzymol; 2006; 417():137-52. PubMed ID: 17132503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex.
    Sciandra F; Bozzi M; Bianchi M; Pavoni E; Giardina B; Brancaccio A
    Ann Ist Super Sanita; 2003; 39(2):173-81. PubMed ID: 14587215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
    Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
    FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.